Thomas J. Tull

St. John's Institute Of Dermatology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.

Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: July 23, 2026

Low dose methotrexate and superpotent topical steroids in the management of bullous pemphigoid.

Low dose methotrexate and superpotent topical steroids in the management of bullous pemphigoid.

Journal: The British journal of dermatology

Published: April 06, 2026

Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.

Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 09, 2026

B cells and humoral immunity in melanoma: regulatory and autoimmune-like features and implications for immunotherapy.

B cells and humoral immunity in melanoma: regulatory and autoimmune-like features and implications for immunotherapy.

Journal: Oncoimmunology

Published: March 07, 2026

The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigus.

The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigus.

Journal: Journal of the American Academy of Dermatology

Published: October 13, 2025

The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigus.

The effect of prior treatment with intravenous immunoglobulin on rituximab pharmacokinetics and treatment outcomes in pemphigus.

Journal: Journal of the American Academy of Dermatology

Published: October 13, 2025

HLA genotype, clinical and immunofluorescence findings of 30 patients with type VII collagen antibody positive subepidermal bullous disease.

HLA genotype, clinical and immunofluorescence findings of 30 patients with type VII collagen antibody positive subepidermal bullous disease.

Journal: Clinical and experimental dermatology

Published: October 09, 2025

Treatment with mycophenolate mofetil as an adjuvant therapy post-rituximab does not improve treatment outcomes in pemphigus.

Treatment with mycophenolate mofetil as an adjuvant therapy post-rituximab does not improve treatment outcomes in pemphigus.

Journal: Clinical and experimental dermatology

Published: October 07, 2025

Clinical correlation of anti-desmoglein antibody dynamics in pemphigus treated with rituximab.

Clinical correlation of anti-desmoglein antibody dynamics in pemphigus treated with rituximab.

Journal: Frontiers in immunology

Published: September 26, 2025

Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: a scoping review.

Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: a scoping review.

Journal: The British journal of dermatology

Published: August 15, 2025

A current need for the use of improved and standardized outcome measures by clinical studies of pemphigus.

A current need for the use of improved and standardized outcome measures by clinical studies of pemphigus.

Journal: The British journal of dermatology

Published: May 16, 2025

Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma.

Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma.

Journal: Journal for immunotherapy of cancer

Published: May 13, 2025

Showing 1-12 of 37

Last Updated: 09/26/2026